Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma

C. Kurokawa, H. Geekiyanage, C. Allen, I. Iankov, M. Schroeder, B. Carlson, K. Bakken, J. Sarkaria, J. A. Ecsedy, A. D’Assoro, B. Friday, E. Galanis

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint

Dive into the research topics of 'Alisertib demonstrates significant antitumor activity in bevacizumab resistant, patient derived orthotopic models of glioblastoma'. Together they form a unique fingerprint.

Medicine & Life Sciences